Evidence map›Paper›PMID 39397225›Full record

ArticleJournal of community genetics2024

Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries.

Erica M Bednar, Roni Nitecki Wilke, Kirsten Jorgensen, Michael T Walsh, Stephanie Nutt, Karen H Lu, Leandro Nóbrega, Aline Patricia Soares Dias De Souza, Gabriela da Silva Oliveira, Carlos Eduardo Mattos da Cunha Andrade and 6 more

Abstract read
In one paragraph

Article in Journal of community genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Erica M BednarCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. embednar@mdanderson.org.ORCID https://orcid.org/0000-0003-3870-2182
Roni Nitecki WilkeDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kirsten JorgensenDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Michael T WalshCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Stephanie NuttCancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Karen H LuDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Leandro NóbregaDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Aline Patricia Soares Dias De SouzaDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Gabriela da Silva OliveiraDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Carlos Eduardo Mattos da Cunha AndradeDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Nelson Purizaca-RosilloEquipo Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Pamela MoraEquipo Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Aldo López BlancoDepartamento de Cirugía Ginecológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Lenny N Gallardo-AlvaradoClinical Research, Instituto Nacional de Cancerologia, Mexico City, Mexico.
David Cantú-de LeónClinical Research, Instituto Nacional de Cancerologia, Mexico City, Mexico.
J Alejandro Rauh-HainDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveClinical cancer genetics services are expanding globally, but national policy and health care systems influence availability and implementation. Understanding the environmental factors within a country is required to appropriately implement, adapt, and evaluate cancer genetics service delivery models. An environmental scan (ES) is an approach used in business, public health, health care and other sectors to collect information about an environment or system for strategic decision making and program planning. An ES has been previously used to assess cancer genetics clinic-level factors to inform quality improvement efforts in the United States. We assessed the feasibility of using an ES to collect information about factors that may influence cancer genetics service delivery in the outer-most socio-ecological model environmental levels (policy, national agencies, healthcare systems, cultural considerations) in three Latin American countries.

methodsOncology and Genetics care team members at three participating sites used publicly available sources and personal experiences to complete a data collection form (DCF) that included questions about subtopics: laws and policies, relevant agencies and regulations, health care systems and insurance, and cultural considerations. Time to complete the DCF and DCF completeness were used to measure ES feasibility.

resultsParticipating sites completed the DCF in 3 months, and most questions (average, 87.0%) were answered. Questions in the cultural considerations subtopic had the fewest answers (average, 77.8%).

conclusionsOverall, the ES was feasible and identified a lack of published literature related to cultural considerations impacting health care and genetics services uptake in Latin America. Environmental factors impact cancer genetics services, and identification of these factors will facilitate future collaborative research and genetics service delivery dissemination efforts.

Indexed as

Environmental scanGenetic counselingGenetic testingHereditary cancerPublic health

Identifiers

PMID39397225
PMCPMC11645378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.